Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C17H11ClNO2S.Ca |
Molecular Weight | 697.663 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ca++].[O-]C(=O)CC1=C(N=C(S1)C2=CC=CC=C2)C3=CC=C(Cl)C=C3.[O-]C(=O)CC4=C(N=C(S4)C5=CC=CC=C5)C6=CC=C(Cl)C=C6
InChI
InChIKey=WGCKYSZZBQAHJJ-UHFFFAOYSA-L
InChI=1S/2C17H12ClNO2S.Ca/c2*18-13-8-6-11(7-9-13)16-14(10-15(20)21)22-17(19-16)12-4-2-1-3-5-12;/h2*1-9H,10H2,(H,20,21);/q;;+2/p-2
Molecular Formula | C17H11ClNO2S |
Molecular Weight | 328.793 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Ca |
Molecular Weight | 40.078 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://imr.sagepub.com/content/11/5/298.full.pdf
Sources: http://imr.sagepub.com/content/11/5/298.full.pdf
Fentiazac is a non-steroidal anti-inflammatory agent developed for the treatment of pain disorders. The drug was marketed under the name Norvedan, however, its current marketing status is unknown and supposed to be "discontinued".
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://imr.sagepub.com/content/11/5/298.full.pdf
6,44 mg/kg as a daily dose.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:30:06 GMT 2023
by
admin
on
Fri Dec 15 17:30:06 GMT 2023
|
Record UNII |
87K2GQ2Q21
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
87K2GQ2Q21
Created by
admin on Fri Dec 15 17:30:06 GMT 2023 , Edited by admin on Fri Dec 15 17:30:06 GMT 2023
|
PRIMARY | |||
|
288-435-4
Created by
admin on Fri Dec 15 17:30:06 GMT 2023 , Edited by admin on Fri Dec 15 17:30:06 GMT 2023
|
PRIMARY | |||
|
SUB02130MIG
Created by
admin on Fri Dec 15 17:30:06 GMT 2023 , Edited by admin on Fri Dec 15 17:30:06 GMT 2023
|
PRIMARY | |||
|
198620
Created by
admin on Fri Dec 15 17:30:06 GMT 2023 , Edited by admin on Fri Dec 15 17:30:06 GMT 2023
|
PRIMARY | |||
|
85721-24-0
Created by
admin on Fri Dec 15 17:30:06 GMT 2023 , Edited by admin on Fri Dec 15 17:30:06 GMT 2023
|
PRIMARY | |||
|
DTXSID80235035
Created by
admin on Fri Dec 15 17:30:06 GMT 2023 , Edited by admin on Fri Dec 15 17:30:06 GMT 2023
|
PRIMARY | |||
|
100000086986
Created by
admin on Fri Dec 15 17:30:06 GMT 2023 , Edited by admin on Fri Dec 15 17:30:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |